These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 467631)

  • 1. On the interpretability of quantitative structure-activity relationships (QSAR).
    Franke R
    Farmaco Sci; 1979 Jun; 34(6):545-70. PubMed ID: 467631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships in the developmental toxicity of substituted phenols: in vivo effects.
    Kavlock RJ
    Teratology; 1990 Jan; 41(1):43-59. PubMed ID: 2305374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE; Polin LA; Palomino E; Brooks SC
    J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-pharmacokinetic/pharmacodynamic relationships.
    Mager DE
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
    Roy K; Leonard JT
    Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks.
    So SS; Karplus M
    J Med Chem; 1996 Mar; 39(7):1521-30. PubMed ID: 8691483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANN-QSAR model of drug-binding to human serum albumin.
    Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
    Opera TI; Waller CL; Marshall GR
    Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of gastro-intestinal absorption using multivariate adaptive regression splines.
    Deconinck E; Xu QS; Put R; Coomans D; Massart DL; Vander Heyden Y
    J Pharm Biomed Anal; 2005 Oct; 39(5):1021-30. PubMed ID: 16040225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
    Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
    Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.